Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial

Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Updated the page revision to v3.5.0 and removed the reference to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:48:16.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:18:34.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the previous funding-status notice and Revision: v3.4.1 banner were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:14:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page displays a government funding status notice and updates the UI version label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T22:41:49.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Glossary toggle added to improve term explanations, and the page now includes a QC-related label ('Last Update Submitted that Met QC Criteria'), a capitalization update for 'No FEAR Act Data', and a new revision tag ('Revision: v3.4.0').
    Difference
    0.2%
    Check dated 2026-01-27T21:10:34.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    Added a Locations section listing participating states and sites (Alabama, Arizona, California, Colorado, Florida, Illinois, Louisiana, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). Updated to Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T00:30:25.000Z thumbnail image

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.